EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC 4.0

Correction to: Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies

The Oncologist · 05.11.2026 · 31 (12)

DOI: 10.1093/oncolo/oyag418 ↗

Kurz gefasst

Korrektur in der Zeitschrift The Oncologist, online erschienen am 05.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to: Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies. The Oncologist, 31(12). https://doi.org/10.1093/oncolo/oyag418

Vancouver

Correction to: Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies. The Oncologist. 2026;31(12). doi:10.1093/oncolo/oyag418

BibTeX
@article{euvimed2026,
  title = {Correction to: Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {12},
  doi = {10.1093/oncolo/oyag418}
}
Kostenlos starten →